Trial Profile

Evaluation of Platelet Aggregation and Adenosine Levels in Patients With Coronary Artery Disease and Chronic Kidney Dysfunction Taking Dual Antiplatelet Therapy With Aspirin and Clopidogrel or Ticagrelor

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 05 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 May 2021 Results (n=105) assessing high on treatment platelet reactivity with Clopidogrel versus Ticagrelor in patients with and without chronic kidney disease presented at the 70th Annual Scientific Session of the American College of Cardiology
21 Apr 2020 Status changed from recruiting to completed.
18 Nov 2019 Results (n=63) evaluating adenosine plasmatic concentration in coronary artery disease patients according to renal function were presented at the American Heart Association Scientific Sessions 2019

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com